Login
Velsera blog - insights on the future of precision medicine
BLOG

Discussing the future of precision medicine.

Level Up your Documentation Processes and Systems to Comply with FDA Final Rule Stages 1 & 2

Level Up your Documentation Processes and Systems to Comply with FDA Final Rule Stages 1 & 2

FDA’s ruling on enforcement of in vitro diagnostic (IVD) medical device requirements for laboratory-developed tests (LDTs) was published in May of 2024. Barring delays from legal or legislative action, enforcement of Stage 1 will begin in 9 months. W...
go to article
Enhancing the Precision Medicine Journey

Enhancing the Precision Medicine Journey

Five Focus Areas for Our Chief Customer Officer
go to article
Get Ready to Comply with FDA Final Rule Stages 1 & 2: Yeah, We Mean You

Get Ready to Comply with FDA Final Rule Stages 1 & 2: Yeah, We Mean You

FDA's New LDT Rule: An Overview
go to article
Navigating your molecular lab’s test selection and development over the next two years

Navigating your molecular lab’s test selection and development over the next two years

With the FDA’s publication of the final rule on laboratory developed tests (LDTs) on May 6, 2024, cl...
go to article
Unravelling Cellular Complexity: Exploring 3D Genome Structure and DNA Methylation with the snM3C Pipeline

Unravelling Cellular Complexity: Exploring 3D Genome Structure and DNA Methylation with the snM3C Pipeline

Understanding the three-dimensional genome architecture is an important feature when analysing gene ...
go to article
Four Years, Five Stages: the FDA's Final Rule on LDTs

Four Years, Five Stages: the FDA's Final Rule on LDTs

After over a decade-long saga, the Food and Drug Administration (FDA) published its final rule on La...
go to article
Making the Most of Multi-Modal Tissue Atlases with Cloud Compute

Making the Most of Multi-Modal Tissue Atlases with Cloud Compute

Why Tissue Atlases? The omics revolution has fundamentally altered our understanding of cellular het...
go to article
Velsera_blog

Meeting the NIH Data Management and Sharing (DMS) policy requirements

The Velsera suite of NIH-funded platforms including Cancer Genomics Cloud (CGC), BioData Catalyst Po...
go to article
Velsera_blog

Teaching Introduction to Bioinformatics on the Cancer Genomics Cloud

Velsera is deeply committed to enabling precision medicine not only through accelerating discoveries...
go to article
Velsera_blog

Highly Customizable Multi-sample Single Cell RNA-Seq Pipeline on CGC

The reasons and rationale behind single-cell RNA-Seq “To study human biology, we must know our cells...
go to article
load more